Denosumab Tied to Infection Risk
Non-Pharmacological Interventions & Management of RA-Related Fatigue
4 Tips to Limit Missed Appointments
RA Patients May Be Less Likely to Discontinue Etanercept Than Other TNF Inhibitors
Novartis, Merck & Allergan Join Those Raising U.S. Drug Prices for 2020
Malignancy Risk Varies with Treatment in Systemic Necrotizing Vasculitis
One-Third of U.S. Healthcare Spending Is Administrative Costs
State Legislative Update: Setting the Stage for 2020 & Beyond
Off-Label Coverage of Mycophenolate for Scleroderma under Medicare Part D
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 595
- Next Page »